Cancer cells produce unique heterogeneous vesicles 1 capable of transferring oncogenic material 2, 3 to other cells 4, 5 , with the potential of modulating a tumoursupportive environment [6] [7] [8] . We have previously reported the presence of lipidenriched, membrane bound sub-cellular vesicles at the periphery of acute lymphoblastic leukemia (ALL) cell lines 9, 10 . We now extend these findings to describe heterogeneous anucleate vesicles released into extracellular fluids in vitro and in vivo by primary B-cell precursor (BCP) ALL blasts and cell lines. Leukemic extracellular vesicles (LEVs) were internalized by stromal cells, and induced a metabolic switch.
Extracellular vesicles (EV's) are enclosed in lipid bilayers originating from the cell of origin, released by both normal and cancer cells 1 . Here, the BCP cell specific membrane protein CD19 present within membrane lipid rafts 11 was used to identify the cell of origin of EV's in clinical samples. We directly compared plasma samples from CD19+ primary BCP-ALL bone marrow aspirates at diagnosis containing >95% malignant blasts with matched remission samples obtained after 28 days of therapy ( Figure 1A , left panel). The diagnostic sample, which predominantly contained BCP ALL cells was significantly enriched in CD19 + vesicles, suggesting that the CD19+ LEVs identified were of leukemic origin. By contrast, CD61 + EV's were increased in remission marrow samples as expected in a regenerating marrow ( Figure 1A , right panel). NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ (NSG) mice are extensively used as a patient derived xenograft model of BCP-ALL, by ourselves 10, 18 and others. PKH26 12 labeled BCP cell line SD1 and LEVs derived from SD1 cells were separately transplanted intrafemorally into NSG mice. Bone marrow flushes taken 17 days later showed transplanted LEVs within a proportion of murine bone marrow stromal cells (BMSC) ( Figure 1B , upper). When labeled SD1 cells were introduced (1B, lower), cells and LEVs were detected within the extracellular space. Confocal microscopy and 3-dimensional modeling confirmed LEV internalization of pre-labelled SD1 LEVs by BMSCs after 24 hours in vitro co-incubation ( Figure 1C ). All transplanted mice showed evidence of PKH26 + , human CD19 + or dual + LEVs in peripheral blood plasma ( Figure 1D ) and femoral flushes (day 14) showed engrafted PKH26 + ALL cells and murine stromal cells with internalized PKH26 + LEVs ( Figure 1E ).
The effect of LEV internalisation by BMSC's was investigated in the human mesenchymal stem cell (MSC) line HS5 13 exposed to LEVs released by the BCP-ALL cell lines SD1 and NALM6. Proliferation and viability assays revealed no significant differences from control (Figure 2A ). Despite a sustained increase in AKT phosphorylation over 24 hours ( Figure 2B ), non-significant reductions in ATP concentrations were observed ( Figure 2C ). Next, the two major energy producing pathways of the cell and parameters of metabolism were assessed. At 24 hours, HS5+LEVs showed a reduced oxygen consumption rate (OCR) compared to control;
were less sensitive to the inhibition of ATP by oligomycin and did not change OCR when electron transport from ATP generation in the mitochondria was uncoupled ( Figure 2D ). Disrupting the electron transport chain (Rotenone/Antimycin A) reduced OCR to a comparable level in all cells, suggesting that the rate of oxygen consumption due to non-mitochondrial sources was comparable. HS5+LEV have a significantly reduced spare respiratory capacity, an indicator of a decreased ability to respond to stress or metabolic challenge ( Figure 2D ). Overall these results suggest that uptake of LEVs significantly reduced mitochondrial respiration in recipient stromal cells.
In the absence of glucose, HS5 and HS5+LEVs had comparable extracellular acidification rates (ECAR) ( Figure 2E ). In the presence of glucose, HS5+LEVs initiated a sharp increase in ECAR compared to control (~5 fold), suggesting a higher glycolytic rate. Inhibiting ATP synthase increased ECAR in both HS5+LEVs and controls, but more sharply in the latter. Following the addition of 2-Deoxy-D-glucose, a competitive inhibitor of glycolysis, ECAR returned to base levels in both control and LEV exposed cells. Thus in the presence of glucose, LEV exposed HS5 showed an increase in ECAR which is suggestive of glycolysis. This was corroborated by the demonstration of significantly increased extracellular lactate production, the end product of aerobic glycolysis, by HS5+LEV ( Figure 2F ). To investigate this further, OCR and ECAR were evaluated in the same cultures simultaneously. A shift towards a glycolytic phenotype was observed in HS5 cells treated with either NALM6 or SD1 LEVs ( Figure 2G ). Overall, these results suggest that uptake of LEVs significantly reduced mitochondrial respiration in recipient stromal cells and their ability to respond oxidatively to stress or metabolic challenge. As ATP levels and proliferation rates were similar in HS5 and HS5+LEV, LEVs induced a metabolic switch from oxidative phosphorylation (OXPHOS) to aerobic glycolysis in stromal cells to meet energy requirements.
Our observations show that both in vitro and in vivo, BCP ALL cells release a variety
of LEVs into the extracellular fluid and circulation which are taken up by BMSC. LEV exposed BMSC undergo a metabolic switch. A similar reprogramming of stromal cells to glycolytic cancer associated fibroblasts 14, 15 has been attributed to exosomes released by chronic lymphocytic leukemia cells 4 . The altered tumour microenvironment promotes leukemic cell survival 16, 17 and protects against cytotoxic effects of chemotherapy. A mechanism of this protective effect of the microenvironment appears to be mediated via an adapation to oxidative stress with decreased mitochondrial electron transfer 18 and a switch to glycolysis 19 . In this study, we show that the reprogrammed stromal cells generate an excess of lactate which is released into the extracellular fluid. We speculate that this lactate is utilised preferentially by tumour cells as a source of energy, a process we have previously termed the reverse Warburg effect 20 . Targeting glycolysis 21 as well as the redox adaptation 18 , has been shown to overcome drug resistance in ALL. Modulating the tumour-stromal metabolic interactions offers the development of novel therapeutic strategies to enhance the therapeutic response in ALL and other cancers. 
(C) Confirmation of LEV internalisation by human bone marrow cells in vitro.
Isolated SD1 LEV's were labelled using a lipophilic tracer (Dio C 18 ; Green). Labelled LEV's were added to cultures of bone marrow cells in glass plates for 24 hours.
Cells were fixed using paraformaldehyde and counterstained using Cell Mask (red). 
(E) Engrafted primary human ALL cells introduced into the mouse bone marrow produce LEVs which are internalised by surrounding mBMSCs.
Primary ALL cells were labelled with PKH26 (red) and introduced into the femur of 5
x NOD-scid IL2rɣ null (NSG) mice. Bone marrow flushes 14 days after injection were 
(B) Co-incubation of BMSCs with ALL LEVs results in activation of AKT.
HS5 cells were seeded into large 10cm cell culture plates at 1.5x10 5 cells and allowed to adhere. LEVs were isolated from 24h serum free RPMI cultures of SD1 cells. HS5 media was replaced with LEV containing conditioned media diluted 1:1 with DMEM/10% FBS and incubated at 37˚C 5% CO 2 . Cells were washed and lysed on ice at 1, 3, 5, and 24 hours. 30µg protein was resolved by gradient SDS-PAGE and transferred to PVDF membrane. Blots were probed for pAKT, and then reprobed for AKT and β-Actin. Figure show 
(C) ATP production by BMSC + LEV is reduced compared to control BMSCs.
ATP production was measured using the Cell Titer Glo assay (Promega) in HS5 cells (G) LEV exposed BMSCs switch to a glycolytic phenotype. HS5 cells were exposed to LEVs from either NALM6 or SD1 cells for 24 hours, then washed and equilibrated in mitochondrial stress test media. Extracellular acidification and oxygen consumption were measured in the same well. While control HS5 cells maintain aerobic respiration, following exposure to LEVs for 24 hours, they switch to a more glycolytic phenotype and become less dependent on mitochondrial respiration. 
